Share This Page
Drug Price Trends for QC STOOL SOFTENER-LAXATIVE TAB
✉ Email this page to a colleague
Average Pharmacy Cost for QC STOOL SOFTENER-LAXATIVE TAB
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| QC STOOL SOFTENER-LAXATIVE TAB | 83324-0135-60 | 0.02887 | EACH | 2025-02-19 |
| QC STOOL SOFTENER-LAXATIVE TAB | 83324-0135-60 | 0.02860 | EACH | 2025-01-29 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Stool Softener-Laxative Tablets
Global Market Overview
The global stool softener market is experiencing significant growth, driven by several key factors. As of 2023, the market size was valued at $1.58 billion and is projected to grow to $1.69 billion in 2024, with a compound annual growth rate (CAGR) of 7.4%[1].
Market Drivers
Several drivers are contributing to the growth of the stool softener market:
- Aging Population: The increasing geriatric population suffering from constipation is a major driver. Older adults are more prone to constipation due to decreased physical activity, dietary changes, and other health conditions[1][4].
- Dietary Changes and Sedentary Lifestyle: The adoption of sedentary lifestyles and changes in dietary habits are leading to higher incidences of constipation, thereby increasing the demand for stool softeners[4].
- Increased Public Awareness: Greater awareness about digestive health and the importance of maintaining regular bowel movements is driving the market[1].
- Healthcare Spending: Higher healthcare spending and the development of more effective stool softener formulations are also significant drivers[1][4].
Market Segmentation
The stool softener market is segmented in various ways:
- By Type: The market includes liquid and softgel capsule forms. Softgel capsules are popular due to their ease of consumption and higher bioavailability[1].
- By Form: The market is segmented into medicines and procedures. Medicines are the dominant segment, with a wide range of over-the-counter (OTC) and prescription options available[1].
- By Mode of Administration: Oral administration is the most common, with rectal administration also available for specific cases[1].
- By Availability: The shift from prescription-only to OTC status for many stool softeners has expanded the market reach. OTC products are increasingly popular due to their convenience and accessibility[1].
- By End Use: The market is segmented into hospitals, clinics, home care, and other end uses. Home care is a significant segment due to the preference for self-medication and home treatment[1].
Regional Analysis
- North America: This region was the largest in the stool softener market in 2023, driven by high healthcare spending and the prevalence of constipation in both adult and pediatric populations[1][4].
- Asia-Pacific: Expected to be the fastest-growing region, driven by increasing investment in research and development, and the expansion of healthcare infrastructure[1][3].
Competitive Landscape
The stool softener market is fairly fragmented, with several large and medium-sized companies. Key players are engaging in mergers and acquisitions, strategic agreements, and the development of new products to maintain market share. For example, Atlantis Consumer Healthcare Inc. acquired several brands from Avrio Health L.P. in June 2023, enhancing its position in the health and wellness sector[1].
Product Overview: QC Stool Softener-Laxative Tablets
Products like the QC Stool Softener-Laxative Tablets are designed to provide gentle and dependable relief from constipation. Here are some key features:
- Active Ingredients: These tablets often contain docusate sodium to soften the stool and plant-derived sennosides to draw water into the gut, facilitating easier bowel movements[2].
- Usage: They are typically taken orally and provide relief within 6 to 12 hours, making them a convenient option for overnight relief[2].
- Labeling Standards: Non-prescription oral stool softener laxatives must comply with specific labeling standards, including warnings about frequent or prolonged use and contraindications such as abdominal pain or nausea[5].
Price Projections
Given the market growth trends, the prices of stool softener-laxative tablets are likely to remain competitive while potentially increasing slightly due to the development of more advanced formulations and the rising costs of healthcare.
- Current Market Size: The global stool softener market is expected to grow from $1.58 billion in 2023 to $2.26 billion by 2028, with a CAGR of 7.5%[1].
- Future Growth: The overall laxative market, which includes stool softeners, is projected to reach $11.26 billion by 2031, with a CAGR of 6.3% from 2024 to 2031[3].
Key Takeaways
- The stool softener market is driven by an aging population, dietary changes, increased public awareness, and higher healthcare spending.
- The market is segmented by type, form, mode of administration, availability, and end use.
- North America is the largest market, while Asia-Pacific is expected to be the fastest-growing region.
- The competitive landscape is fragmented, with key players focusing on product innovation and strategic acquisitions.
- Products like QC Stool Softener-Laxative Tablets offer gentle and dependable relief, adhering to strict labeling standards.
FAQs
1. What are the primary drivers of the stool softener market? The primary drivers include an aging population, dietary changes, increased public awareness about digestive health, and higher healthcare spending.
2. Which region is expected to be the fastest-growing in the stool softener market? Asia-Pacific is expected to be the fastest-growing region, driven by increasing investment in research and development and the expansion of healthcare infrastructure.
3. What are the common active ingredients in stool softener-laxative tablets? Common active ingredients include docusate sodium and plant-derived sennosides.
4. How is the competitive landscape of the stool softener market? The market is fairly fragmented, with several large and medium-sized companies engaging in mergers and acquisitions, strategic agreements, and product innovation.
5. What are the labeling standards for non-prescription oral stool softener laxatives? These products must comply with standards that include warnings about frequent or prolonged use, contraindications, and specific dosage instructions[5].
Cited Sources:
- The Business Research Company, Stool Softener Global Market Report 2024.
- Target, Laxative With Stool Softener Tablets - 100ct - up&up™.
- Data Bridge Market Research, Global Laxative Market – Industry Trends and Forecast to 2031.
- Emergen Research, Stool Softener Industry Trend, Forecast [2021-2030] | Market ....
- Health Canada, Non-prescription Oral Stool Softener Laxatives Labelling Standard.
More… ↓
